Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$168M Buy
422,051
+10,236
+2% +$2.91M 0.04% 308
2026
Q1
$71.4M Buy
411,815
+21,274
+5% +$4.36M 0.02% 508
2025
Q4
$100M Buy
390,541
+1,755
+0.5% +$460K 0.03% 401
2025
Q3
$101M Sell
388,786
-41,006
-10% -$10.8M 0.03% 408
2025
Q2
$105M Sell
429,792
-217,297
-34% -$54.2M 0.03% 382
2025
Q1
$171M Sell
647,089
-16,732
-3% -$4.53M 0.05% 292
2024
Q4
$168M Sell
663,821
-457,232
-41% -$123M 0.05% 285
2024
Q3
$355M Buy
1,121,053
+177,524
+19% +$63.2M 0.1% 174
2024
Q2
$353M Sell
943,529
-14,704
-2% -$4.96M 0.1% 156
2024
Q1
$332M Buy
958,233
+52,916
+6% +$20.1M 0.1% 179
2023
Q4
$415M Buy
905,317
+80,284
+10% +$39.6M 0.13% 137
2023
Q3
$401M Sell
825,033
-505
-0.1% -$237K 0.14% 135
2023
Q2
$369M Buy
825,538
+18,473
+2% +$9.3M 0.13% 137
2023
Q1
$392M Buy
807,065
+117,245
+17% +$58M 0.15% 137
2022
Q4
$353M Sell
689,820
-248,558
-26% -$131M 0.14% 147
2022
Q3
$455M Sell
938,378
-38,868
-4% -$18.9M 0.18% 113
2022
Q2
$457M Buy
977,246
+123,013
+14% +$54.7M 0.18% 118
2022
Q1
$373M Sell
854,233
-24,897
-3% -$10.4M 0.12% 161
2021
Q4
$408M Sell
879,130
-30,118
-3% -$13.3M 0.12% 156
2021
Q3
$354M Sell
909,248
-79,236
-8% -$33.6M 0.11% 172
2021
Q2
$438M Sell
988,484
-142,475
-13% -$62.2M 0.13% 148
2021
Q1
$474M Sell
1,130,959
-215,974
-16% -$86.2M 0.15% 131
2020
Q4
$553M Buy
1,346,933
+27,335
+2% +$11.4M 0.19% 114
2020
Q3
$546M Buy
1,319,598
+76,136
+6% +$30.6M 0.21% 98
2020
Q2
$482M Sell
1,243,462
-62,333
-5% -$23.3M 0.2% 97
2020
Q1
$410M Buy
1,305,795
+182,753
+16% +$61.6M 0.2% 109
2019
Q4
$412M Buy
1,123,042
+444,585
+66% +$141M 0.16% 132
2019
Q3
$173M Sell
678,457
-28,454
-4% -$7.98M 0.07% 261
2019
Q2
$188M Buy
706,911
+690,246
+4,142% +$175M 0.07% 267
2019
Q1
$4.43M Sell
16,665
-20,663
-55% -$5.95M 0.02% 526
2018
Q4
$10.7M Sell
37,328
-121,629
-77% -$38.6M 0.07% 384
2018
Q3
$53.8M Buy
158,957
+8,834
+6% +$2.87M 0.29% 70
2018
Q2
$44.7M Buy
150,123
+7,665
+5% +$2.24M 0.28% 84
2018
Q1
$38.3M Sell
142,458
-2,352
-2% -$637K 0.25% 106
2017
Q4
$35.9M Buy
144,810
+10,575
+8% +$2.61M 0.23% 119
2017
Q3
$32.7M Sell
134,235
-10,245
-7% -$2.51M 0.21% 123
2017
Q2
$34.8M Buy
144,480
+106,884
+284% +$24.2M 0.22% 108
2017
Q1
$7.75M Sell
37,596
-2,826
-7% -$584K 0.05% 460
2016
Q4
$8.25M Buy
40,422
+13,862
+52% +$2.64M 0.04% 510
2016
Q3
$4.7M Buy
26,560
+13,812
+108% +$2.4M 0.03% 541
2016
Q2
$2.29M Sell
12,748
-42
-0.3% -$7.46K 0.01% 691
2016
Q1
$2.34M Sell
12,790
-2,752
-18% -$477K 0.01% 688
2015
Q4
$2.77M Sell
15,542
-20,590
-57% -$3.61M 0.01% 636
2015
Q3
$6.47M Sell
36,132
-31,295
-46% -$5.78M 0.04% 420
2015
Q2
$12.9M Buy
67,427
+50,365
+295% +$9.35M 0.07% 329
2015
Q1
$3.04M Sell
17,062
-971
-5% -$154K 0.02% 669
2014
Q4
$2.59M Sell
18,033
-32,805
-65% -$4.48M 0.01% 743
2014
Q3
$6.62M Sell
50,838
-5,286
-9% -$672K 0.04% 458
2014
Q2
$7.17M Buy
56,124
+5,030
+10% +$596K 0.04% 451
2014
Q1
$5.76M Buy
51,094
+5,645
+12% +$588K 0.03% 487
2013
Q4
$4.69M Buy
45,449
+33,019
+266% +$3.23M 0.03% 531
2013
Q3
$1.16M Buy
12,430
+140
+1% +$12.8K 0.01% 1033
2013
Q2
$1.04M Buy
+12,290
New +$970K 0.01% 1012

Other funds holding HUM

Nuveen's HUM Position: Q2 2026 in Review

Nuveen increased its Humana (HUM) stake by 2.5% in Q2 2026, buying an estimated $2.91M and bringing the position to 422,051 shares worth $168M. The position accounts for 0.04% of the portfolio, ranked #308.

Nuveen first reported a position in HUM in Q2 2013 and has held it in 53 quarters since. The position peaked at $553M in Q4 2020. 923 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Nuveen held 422,051 shares of Humana worth $168M as of Q2 2026.
  • Nuveen bought 10,236 Humana shares in Q2 2026, an estimated $2.91M.
  • Humana made up 0.04% of Nuveen's portfolio in Q2 2026, its #308 holding.
  • Nuveen first reported a position in Humana in Q2 2013 and has held it in 53 quarters since.
  • Nuveen's Humana position peaked at $553M in Q4 2020.
  • 923 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.